IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 18 filers reported holding IMMUNE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,000 | -28.6% | 25,000 | 0.0% | 0.00% | -57.1% |
Q3 2016 | $7,000 | -30.0% | 25,000 | 0.0% | 0.01% | -46.2% |
Q2 2016 | $10,000 | -9.1% | 25,000 | 0.0% | 0.01% | -13.3% |
Q1 2016 | $11,000 | -57.7% | 25,000 | -28.6% | 0.02% | -6.2% |
Q4 2015 | $26,000 | -36.6% | 35,000 | 0.0% | 0.02% | -57.9% |
Q3 2015 | $41,000 | -39.7% | 35,000 | 0.0% | 0.04% | -9.5% |
Q2 2015 | $68,000 | +7.9% | 35,000 | 0.0% | 0.04% | 0.0% |
Q1 2015 | $63,000 | -4.5% | 35,000 | 0.0% | 0.04% | +16.7% |
Q4 2014 | $66,000 | -50.7% | 35,000 | -12.5% | 0.04% | -62.1% |
Q3 2014 | $134,000 | – | 40,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Geduld E E | 35,000 | $66,000 | 0.04% |
Ifrah Financial Services, Inc. | 20,956 | $40,000 | 0.02% |
Bank Pictet & Cie (Europe) AG | 12,900 | $25,000 | 0.01% |
Pine River Capital Management L.P. | 250,000 | $286,000 | 0.00% |
Spark Investment Management LLC | 13,500 | $25,000 | 0.00% |
A.R.T. Advisors, LLC | 10,201 | $19,000 | 0.00% |
CITIGROUP INC | 346 | $1,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 32,745 | $62,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20,000 | $38,000 | 0.00% |
MORGAN STANLEY | 126 | $0 | 0.00% |